American Clinical Laboratory Association

Join us on February 23, 2027 in Washington, DC for the ACLA 2027 Annual Meeting as we bring together the nation’s leading clinical laboratories with influential health care policy leaders, including invited Administration officials, for a day of discussions and inside-the-beltway analysis of issues impacting diagnostics. Sessions will feature key policy priorities in the new Congress as well as critical reimbursement and regulatory topics impacting ACLA members’ mission of expanding patient access to the next generation of personalized medicine.

In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS’s flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. ACLA urges Congress to protect access to quality laboratory diagnostics and services by enacting long-term PAMA reform through the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.

Learn More

ACLA launched a new digital ad series urging Congress to protect patient access to essential laboratory services by passing the RESULTS Act (H.R. 5269 / S. 2761). The ads are part of ACLA’s ongoing Stop Lab Cuts campaign and incorporate key themes from its Power of Knowing initiative.

ACLA’s 2026 advocacy agenda demonstrates the association’s commitment to advancing policy in the areas of reimbursement, regulation, infrastructure for preparedness and response, innovation, and public affairs. The advocacy agenda summarizes our goals to expand access to the highest quality clinical laboratory services, improve patient outcomes, and advance the next generation of personalized care.